Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,801 | 775 | 707 | 614 | 983 |
| Operating Income | -1,801 | -775 | -707 | -614 | -983 |
| Interest Expense | 1 | 2 | 3 | 4 | 1 |
| Other Income | -178 | 1 | 0 | -3 | 1 |
| Pre-tax Income | -1,980 | -776 | -710 | -621 | -983 |
| Net Income Continuous | -1,980 | -776 | -710 | -621 | -983 |
| Net Income | $-1,980 | $-776 | $-710 | $-618 | $-986 |
| EPS Basic Total Ops | -0.33 | -0.29 | -0.29 | -0.27 | -0.44 |
| EPS Basic Continuous Ops | -0.32 | -0.29 | -0.29 | -0.28 | -0.44 |
| EPS Diluted Total Ops | -0.33 | -0.29 | -0.29 | -0.27 | -0.44 |
| EPS Diluted Continuous Ops | -0.32 | -0.29 | -0.29 | -0.28 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -0.33 | -0.29 | -0.29 | -0.27 | -0.44 |
| EBITDA(a) | $-1,801 | $-775 | $-707 | $-614 | $-983 |